{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T01:43:20Z","timestamp":1767923000249,"version":"3.49.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:00:00Z","timestamp":1633910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Severe Crohn\u2019s disease [CD] can result in extensive bowel resections and need for creation of an ileostomy. Faecal calprotectin [FC] is well studied in CD management, though its role in patients who have an ileostomy is unclear. Our aim is to understand if FC is a useful adjunct to radiographic or endoscopic studies in identifying recurrent CD after surgery in patients with an ileostomy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Between January 1, 2017, and September 30, 2020, we searched the Mayo Clinic electronic medical record retrospectively for adult patients with ICD-10 code for CD, and a surgical history of an ileostomy. Patients were included in the analysis if they had at least one FC measured and a concomitant radiographic imaging and\/or endoscopic procedure. An abnormal FC was defined as greater than 60 \u00b5g\/g.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 51 patients who met our inclusion criteria, 17 had an FC level &amp;gt;60 \u00b5g\/g. Of these 17 patients, 14 had imaging and\/or an ileoscopy confirming the presence of small bowel inflammation, with a sensitivity of 87.5%. Of the remaining 34 patients with an FC level \u226460 \u00b5g\/g, 32 patients had imaging and\/or ileoscopy demonstrating no small bowel inflammation, with a specificity of 91.4%. FC from an ileostomy effluent had a positive predictive value of 82.3%, a negative predictive value of 94.1% and test diagnostic accuracy of 90.1%.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>FC from an ileostomy effluent is a highly sensitive and specific test for the assessment and monitoring of small bowel inflammation and disease recurrence in patients with CD.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ecco-jcc\/jjab182","type":"journal-article","created":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T12:24:23Z","timestamp":1633782263000},"page":"601-605","source":"Crossref","is-referenced-by-count":15,"title":["Faecal Calprotectin from Ileostomy Output Is Sensitive and Specific for the Prediction of Small Bowel Inflammation in Patients with Crohn\u2019s Disease"],"prefix":"10.1093","volume":"16","author":[{"given":"Nader D","family":"Daoud","sequence":"first","affiliation":[{"name":"Inflammatory Bowel Disease Center, Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana G","family":"Hashash","sequence":"additional","affiliation":[{"name":"Inflammatory Bowel Disease Center, Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael F","family":"Picco","sequence":"additional","affiliation":[{"name":"Inflammatory Bowel Disease Center, Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis A","family":"Farraye","sequence":"additional","affiliation":[{"name":"Inflammatory Bowel Disease Center, Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,10,11]]},"reference":[{"key":"2022051016282494300_CIT0001","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ajg.2018.27","article-title":"ACG Clinical guideline: management of Crohn\u2019s disease in adults","volume":"113","author":"Lichtenstein","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"2022051016282494300_CIT0002","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10620-012-2371-5","article-title":"Recent trends in the prevalence of Crohn\u2019s disease and ulcerative colitis in a commercially insured US population","volume":"58","author":"Kappelman","year":"2013","journal-title":"Dig Dis Sci"},{"key":"2022051016282494300_CIT0003","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.sapharm.2016.05.042","article-title":"An evaluation of health care expenditures in Crohn\u2019s disease using the United States Medical Expenditure Panel Survey from 2003 to 2013","volume":"13","author":"Bounthavong","year":"2017","journal-title":"Res Social Adm Pharm"},{"key":"2022051016282494300_CIT0004","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.3748\/wjg.v22.i14.3860","article-title":"Cost-effectiveness of Crohn\u2019s disease post-operative care","volume":"22","author":"Wright","year":"2016","journal-title":"World J Gastroenterol"},{"key":"2022051016282494300_CIT0005","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.clinbiochem.2011.10.015","article-title":"Ruling out IBD: estimation of the possible economic effects of pre-endoscopic screening with F-calprotectin","volume":"45","author":"Mindemark","year":"2012","journal-title":"Clin Biochem"},{"key":"2022051016282494300_CIT0006","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/jgh.14950","article-title":"Is faecal calprotectin an accurate marker in the management of Crohn\u2019s disease?","volume":"35","author":"Vernia","year":"2020","journal-title":"J Gastroenterol Hepatol"},{"key":"2022051016282494300_CIT0007","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.cca.2020.08.025","article-title":"Calprotectin in inflammatory bowel disease","volume":"510","author":"Khaki-Khatibi","year":"2020","journal-title":"Clin Chim Acta"},{"key":"2022051016282494300_CIT0008","doi-asserted-by":"crossref","first-page":"384","DOI":"10.14309\/ajg.0000000000000152","article-title":"ACG Clinical guideline: ulcerative colitis in adults","volume":"114","author":"Rubin","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"2022051016282494300_CIT0009","article-title":"Biochemical biomarkers of mucosal healing for inflammatory bowel disease in adults","volume":"10:367","author":"Krzystek-Korpacka","year":"2020","journal-title":"Diagnostics"},{"key":"2022051016282494300_CIT0010","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1515\/cclm-2013-0588","article-title":"Inflammatory bowel diseases: from pathogenesis to laboratory testing","volume":"52","author":"Basso","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"2022051016282494300_CIT0011","first-page":"21","article-title":"aecal calprotectin in inflammatory bowel disease","volume":"9","author":"Walsham","year":"2016","journal-title":"Clin Exp Gastroenterol"},{"key":"2022051016282494300_CIT0012","doi-asserted-by":"crossref","first-page":"c3369","DOI":"10.1136\/bmj.c3369","article-title":"Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis","volume":"341","author":"van Rheenen","year":"2010","journal-title":"BMJ"},{"key":"2022051016282494300_CIT0013","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/ecco-jcc\/jjy187","article-title":"Faecal calprotectin and magnetic resonance enterography in ileal Crohn\u2019s disease: correlations between disease activity and long-term follow-up","volume":"13","author":"Jones","year":"2019","journal-title":"J Crohns Colitis"},{"key":"2022051016282494300_CIT0014","doi-asserted-by":"crossref","first-page":"8235","DOI":"10.3748\/wjg.v23.i46.8235","article-title":"Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: a prospective study in China","volume":"23","author":"Chen","year":"2017","journal-title":"World J Gastroenterol"},{"key":"2022051016282494300_CIT0015","doi-asserted-by":"crossref","first-page":"580803","DOI":"10.3389\/fmed.2020.580803","article-title":"Global studies of using faecal biomarkers in predicting relapse in inflammatory bowel disease","volume":"7","author":"Liu","year":"2020","journal-title":"Front Med"},{"key":"2022051016282494300_CIT0016","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11894-016-0499-8","article-title":"A practical approach to preventing postoperative recurrence in Crohn\u2019s disease","volume":"18","author":"Hashash","year":"2016","journal-title":"Curr Gastroenterol Rep"},{"key":"2022051016282494300_CIT0017","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1586\/egh.12.45","article-title":"The evolving management of postoperative Crohn\u2019s disease","volume":"6","author":"Hashash","year":"2012","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"2022051016282494300_CIT0018","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.3748\/wjg.v24.i33.3681","article-title":"From bench to bedside: faecal calprotectin in inflammatory bowel diseases clinical setting","volume":"24","author":"Mumolo","year":"2018","journal-title":"World J Gastroenterol"},{"key":"2022051016282494300_CIT0019","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ajg.2009.579","article-title":"The natural history of adult Crohn\u2019s disease in population-based cohorts","volume":"105","author":"Peyrin-Biroulet","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"2022051016282494300_CIT0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2021.03.048","article-title":"Advances in the comprehensive management of postoperative Crohn\u2019s disease","author":"Battat","year":"2021.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2022051016282494300_CIT0021","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/DCR.0000000000001263","article-title":"Profile of consecutive faecal calprotectin levels in the perioperative period and its predictive capacity for early endoscopic recurrence in Crohn\u2019s disease","volume":"62","author":"Liu","year":"2019","journal-title":"Dis Colon Rectum"},{"key":"2022051016282494300_CIT0022","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1097\/MIB.0000000000000960","article-title":"aecal calprotectin levels are closely correlated with the absence of relevant mucosal lesions in postoperative Crohn\u2019s disease","volume":"22","author":"Garcia-Planella","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"2022051016282494300_CIT0023","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4240\/wjgs.v8.i3.193","article-title":"Relevance of faecal calprotectin and lactoferrin in the post-operative management of inflammatory bowel diseases","volume":"8","author":"Caccaro","year":"2016","journal-title":"World J Gastrointest Surg"},{"key":"2022051016282494300_CIT0024","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.dld.2011.12.018","article-title":"Diagnosis, prevention and treatment of postoperative Crohn\u2019s disease recurrence","volume":"44","author":"Buisson","year":"2012","journal-title":"Dig Liver Dis"},{"key":"2022051016282494300_CIT0025","doi-asserted-by":"crossref","first-page":"E196","DOI":"10.1002\/ibd.21730","article-title":"Should we monitor Crohn\u2019s disease patients for postoperative recurrence after permanent ileostomy?","volume":"18","author":"Leal-Valdivieso","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"2022051016282494300_CIT0026","doi-asserted-by":"crossref","first-page":"e641","DOI":"10.1016\/j.crohns.2013.05.005","article-title":"A new rapid test for faecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn\u2019s disease","volume":"7","author":"Lobat\u00f3n","year":"2013","journal-title":"J Crohns Colitis"},{"key":"2022051016282494300_CIT0027","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/MOG.0000000000000737","article-title":"Practical insights into stomas in inflammatory bowel disease: what every healthcare provider needs to know","volume":"37","author":"Estrada","year":"2021","journal-title":"Curr Opin Gastroenterol"},{"key":"2022051016282494300_CIT0028","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1002\/ibd.22917","article-title":"aecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease","volume":"18","author":"D\u2019Haens","year":"2012","journal-title":"Inflamm Bowel Dis"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/advance-article-pdf\/doi\/10.1093\/ecco-jcc\/jjab182\/41042936\/jjab182.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/16\/4\/601\/43654929\/jjab182.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/16\/4\/601\/43654929\/jjab182.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T16:30:07Z","timestamp":1652200207000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article\/16\/4\/601\/6388201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,11]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,10,11]]},"published-print":{"date-parts":[[2022,5,10]]}},"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjab182","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"value":"1873-9946","type":"print"},{"value":"1876-4479","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,4,1]]},"published":{"date-parts":[[2021,10,11]]}}}